Forum Replies Created
-
Replies
-
Hi all,
As a study we invited the CAB as a key stakeholder to visit our labs, this process assisted to eliminate speculations that go with drawing of blood. The CAB is now able to explain fully to the community the pathway of blood samples. The other key stakeholder that we engaged are communities living with HIV. This relationship has helped us gain more information on the general expectations of this community. We have also been able to grow this relationship by training representatives of communities of people living with HIV. This has been a great opportunity to share research literacy which will in turn be rolled out to the various organisations of communities of people living with HIV.
Hi Anja,
Glad to hear from you. I work for an organization called Zambart. It is also involved in an Aeras TB Vaccine study in Zambia. I am not on the study but we are working together around community stakeholder involvement.
Hi Denver,
In our communities 90% of transmission is heterosexual with this means that the general population is highly affected. The PMTCT programme has been very successful in ensuring reducing the number of babies born with HIV. Currently our Ministry of Health is emplementing the option B plus which recommends for all HIV positive pregnant mothers to be initiated on ART.
Hello everyone,
I feel the lead research team has a good understanding of stakeholder engagement. This may not necessarily be so with the field teams who form a large component of the study. At site or district level the site management team has a good understanding of stakeholder engagement as they are involved in planning and conducting of stakeholder meetings. Our CAB members are involved in advising study participants and resolving of incidents. This has helped in ‘marketing’ them.
